文献速递脑血管病

胰腺β细胞功能与非糖尿病缺血性卒中患者预后

Pancreatic β-Cell Function and Prognosis of Nondiabetic Patients With Ischemic Stroke.
PubMed 文献 · Stroke · 2017-09-27

基于ACROSS-China登记中1171例无糖尿病史的缺血性卒中患者,利用空腹C肽估算处置指数评估β细胞功能。随访12个月发现,处置指数最低四分位与卒中复发和依赖风险升高相关,最低两个四分位与死亡风险升高相关,处置指数与各终点风险呈L形关联。

要点

  • 无糖尿病缺血性卒中患者中β细胞功能下降与12个月不良预后相关
  • 处置指数最低四分位者卒中复发风险显著升高
  • 处置指数与卒中复发、死亡和依赖风险呈L形关联

核心结论

  • 在无糖尿病史的缺血性卒中患者中,β细胞功能障碍与12个月不良预后风险升高相关。

研究设计与样本

  • 基于ACROSS-China登记纳入无糖尿病史的缺血性卒中患者,共1171例,37.2%为女性,平均年龄62.4岁。
  • 处置指数按基于空腹C肽的稳态模型评估2-β%与稳态模型评估2-胰岛素抵抗之比估算。

主要发现

  • 12个月时167例(14.8%)复发卒中,110例(9.4%)死亡,184例(16.0%)依赖(改良Rankin量表3-5分)。
  • 处置指数第一四分位与卒中复发风险升高相关(校正风险比3.57;95%CI 2.13-5.99)。
  • 处置指数第一四分位与依赖风险升高相关(校正风险比2.30;95%CI 1.21-4.38)。
  • 与第四四分位相比,处置指数第一和第二四分位与死亡风险升高相关(校正风险比5.09;95%CI 2.51-10.33;校正风险比2.42;95%CI 1.17-5.03)。
  • 限制性立方样条多变量回归显示处置指数与各终点风险呈L形关联。

临床怎么用

  • 对无糖尿病史的缺血性卒中患者,可关注基于空腹C肽估算的β细胞功能以辅助识别预后不良高危人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Pancreatic β-cell dysfunction is an important factor in the development of type 2 diabetes mellitus. This study aimed to estimate the association between β-cell dysfunction and prognosis of nondiabetic patients with ischemic stroke. METHODS: Patients with ischemic stroke without a history of diabetes mellitus in the ACROSS-China (Abnormal Glucose Regulation in Patients with Acute Stroke across China) registry were included. Disposition index was estimated as computer-based model of homeostatic model assessment 2-β%/homeostatic model assessment 2-insulin resistance based on fasting C-peptide level. Outcomes included stroke recurrence, all-cause death, and dependency (modified Rankin Scale, 3-5) at 12 months after onset. RESULTS: Among 1171 patients, 37.2% were women with a mean age of 62.4 years. At 12 months, 167 (14.8%) patients had recurrent stroke, 110 (9.4%) died, and 184 (16.0%) had a dependency. The first quartile of the disposition index was associated with an increased risk of stroke recurrence (adjusted hazard ratio, 3.57; 95% confidence interval, 2.13-5.99) and dependency (adjusted hazard ratio, 2.30; 95% confidence interval, 1.21-4.38); both the first and second quartiles of the disposition index were associated with an increased risk of death (adjusted hazard ratio, 5.09; 95% confidence interval, 2.51-10.33; adjusted hazard ratio, 2.42; 95% confidence interval, 1.17-5.03) compared with the fourth quartile. Using a multivariable regression model with restricted cubic spline, we observed an L-shaped association between the disposition index and the risk of each end point. CONCLUSIONS: In this large-scale registry, β-cell dysfunction was associated with an increased risk of 12-month poor prognosis in nondiabetic patients with ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Pan Y, Chen W, Jing J, et al. Pancreatic β-Cell Function and Prognosis of Nondiabetic Patients With Ischemic Stroke. Stroke. 2017. PMID: 28954919. doi:10.1161/STROKEAHA.117.018203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。